Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 17/11/2017
SIETES contiene 92128 citas

 
 
 1 a 20 de 737 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Schröder C, Dörcks M, Kollhorst B, Blenk T, Dittmann RW, Garbe E, Riedel O. Extent and risks of antidepressant off-label use in children and adolescents in Germany between 2004 and 2011. Pharmacoepidemiol Drug Saf 2017;26:1395-402. [Ref.ID 102134]
2. Cita con resumen
Burcu M, Zito JM, Safer DJ, Magder LS, dos-Reis S, Shaya FT, Rosenthal GL. Association of antidepressant medications with incident type 2 diabetes among Medicaid-insured youths. JAMA Pediatrics 2017:16 de octubre. [Ref.ID 102122]
3. Cita con resumen
Morkem R, Williamson T, Patten S, Queenan JA, Wong ST, Manca D, Barber D. Trends in antidepressant prescribing to children and adolescents in Canadian primary care: A time-series analysis. Pharmacoepidemiol Drug Saf 2017;26:1093-9. [Ref.ID 102065]
4. Cita con resumen
Anónimo. FDA Approves CAR-T therapy for treatment of childhood leukemia. DIA Daily 2017:1. [Ref.ID 102036]
5. Cita con resumen
Ford BM, Tai S, Fantegrossi WE, Prather PL. Synthetic pot: not your grandfathers marijuana. Trends Pharmacol Sci 2017;38:257-76. [Ref.ID 101989]
6. Cita con resumen
Schröder C, Dörks M, Kollhorst B, Blenk T, Dittmann RW, Garbe E, Riedel O. Outpatient antidepressant drug use in children and adolescents in Germany between 2004 and 2011. Pharmacoepidemiol Drug Saf 2017;26:170-9. [Ref.ID 101952]
8. Cita con resumen
Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, Korbee LL, Porter LL, Hershey AD, for the CHAMP Investigators. Trial of amitriptyline, topiramate, and placebo for pediatric migraine. N Engl J Med 2017;376:115-24. [Ref.ID 101371]
9. Cita con resumen
Anónimo. Rilpivirine et HIV chez les adolescents. Prescrire 2017;37:13-4. [Ref.ID 101362]
10. Cita con resumen
Anonimo. Study 329: Why is it so important?. Therapeutics Initiative 1016:1-2. [Ref.ID 100955]
12. Cita con resumen
Gaither JR, Leventhal JM, Ryan SA, et al.. National trends in hospitalizations for opioid poisonings among children and adolescents, 1997 to 2012. JAMA Pediatrics 2016:31 de octubre. [Ref.ID 100870]
13. Cita con resumen
Ahmad SS, Reinius MAV, Hatcher HM, Ajithkumar TV. Anticancer chemotherapy in teenagers and young adults: managing long term side effects. BMJ 2016;354:i4567. [Ref.ID 100740]
14.Tiene citas relacionadas Cita con resumen
Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet 2016;388:881-90. [Ref.ID 100612]
15.Tiene citas relacionadas Cita con resumen
Jureidini J. Antidepressants fail, but no cause for therapeutic gloom. Lancet 2016;388:844-5. [Ref.ID 100611]
16. Cita con resumen
Anónimo. FDA approves Differin Gel 0.1% for over-the-counter use to treat acne. FDA U.S. Food and Drug Administration 2016:8 de julio. [Ref.ID 100485]
17. Cita con resumen
Jackson JW. The cardiovascular safety of methylphenidate. BMJ 2016;353:i2874. [Ref.ID 100356]
19. Cita con resumen
Wise J. Number of children given antidepressants is rising, study shows. BMJ 2016;352:i1457. [Ref.ID 100331]
20.Tiene citas relacionadas Cita con resumen
Chan E, Fogler JM, Hammemess PG. Treatment of attention-deficit/hyperactivity disorder in adolescents: a systematic review. JAMA 2016;315:1997-2008. [Ref.ID 100290]
Seleccionar todas
 
 1 a 20 de 737 siguiente >>